Teens often spend hours daily watching videos online, but parents should consider how the content affects their well-being ...

Celltrion today announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) ...

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company"), a global biopharmaceutical company, and mAbxience ("mAbxience") today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

Amneal Pharmaceuticals (AMRX) “announced that the FDA has accepted for review its Biologics Licensing Application for two proposed denosumab ...

February brought policy updates and several biosimilar approvals, including the first FDA approval for an insulin aspart biosimilar.

Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a ...

Women's Health Therapeutics Market Rising Awareness and Government Initiatives Drive Growth AUSTIN, TX, UNITED STATES, February 28, 202 ...

Number 4: Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its ...

In this article, we explore how aging impacts the musculoskeletal system and share expert-backed prevention tips to help you ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

Amgen released financial results for the 4th quarter of 2024. Check out why I continue to cover AMGN stock with a 'Buy' ...

Osteoporosis, often called a silent disease, weakens bones and increases the risk of fractures, making it a leading cause of ...